Related Experiment Videos
A model for testing compounds influencing porphyrin synthesis
The International Journal of Biochemistry
|January 1, 1986
Summary
Antimalarial drugs chloroquine and pyrimethamine reduce total porphyrin synthesis in yeast models. Pyrimethamine is more effective, showing potential for treating porphyria cutanea tarda.
Area of Science:
- Biochemistry
- Pharmacology
- Yeast Genetics
Background:
- Porphyria cutanea tarda is a metabolic disorder characterized by porphyrin accumulation.
- Antimalarial drugs are explored for therapeutic potential in porphyria cutanea tarda.
- Saccharomyces cerevisiae serves as a model organism for studying cellular processes.
Purpose of the Study:
- To investigate the effects of chloroquine and pyrimethamine on total porphyrin synthesis.
- To determine the impact of these drugs on intracellular to extracellular porphyrin concentration ratios.
- To evaluate the therapeutic potential of combined drug treatment for porphyria cutanea tarda.
Main Methods:
- Cultivation of Saccharomyces cerevisiae under semi-anaerobic conditions in synthetic medium.
- Quantification of total porphyrin synthesis.
- Measurement of intracellular and extracellular porphyrin concentrations.
- Analysis of porphyrin release and permeation dynamics.
Main Results:
- Both chloroquine and pyrimethamine significantly reduced total porphyrin synthesis, with pyrimethamine demonstrating greater efficacy.
- Antagonistic effects on porphyrin release from cells were observed for both drugs.
- Chloroquine decreased the intracellular to extracellular porphyrin ratio, while pyrimethamine increased it, suggesting altered permeation.
Conclusions:
- Pyrimethamine exhibits superior efficacy over chloroquine in reducing porphyrin synthesis.
- The drugs influence porphyrin transport mechanisms, affecting cellular release and permeation.
- Combined therapy with chloroquine and pyrimethamine may offer a promising therapeutic strategy for porphyria cutanea tarda.